The Raju Chaganti Lab: Publications

Visit PubMed for a full listing of Raju Chaganti’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Chaganti, R.S.K., and Nanjangud, G. Cytogenetics of lymphoma. In: Non-Hodgkin’s lymphomas (Mauch, P.M., Armitage, J.O., Coiffier, B., and Dalla-Favera, R., Harris, N.L., eds.) Lippincott, Williams & Wilkins, Baltimore, pp809-824, 2003.

Pasqualucci, L., Migliazza, A., Chaganti, R.S.K., Ye, H. B., and Dalla-Favera, R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101: 2914-2923, 2003.

Teruya-Feldstein, J., Donnelly, G., Goy, A., Hegde, A., Nanjangud, G., Qin, J., Thaler, H., Gillies, F., Dyomin, V.G., Lloyd, K.O., Zelenetz, A.D., Houldsworth, J., and Chaganti, R.S.K. MUC-1 mucin expression correlates with advanced stage disease, adverse event-free and overall survival in diffuse large B-cell lymphoma. Appl. Immunohistochem. Mol. Morph. 11:28-32, 2003.

Houldsworth, J., Olshen, A.B., Cattoretti, G., Donnelly, G.B., Teruya-Feldstein, J., Qin, J., Palanisamy, N., Shen, Y., Dyomina, K., Petlakh, M., Pan, Q., Zelenetz, A.D., and Chaganti, R.S.K. Relationship between REL amplification, REL function, and clinical and biological feaures of diffuse large B-cell lymphoma. Blood. 103: 1862-1868, 2004.

Koul, S., McKiernan, J.M., Narayan, G., Houldsworth, J., Bacik, J., Dobrzynski, D.L., Assad, A.M., Manshukani, M., Reuter, V.E., Bosl, G.J., Chaganti, R.S.K., and Murty, V.V.V.S. Role of promoter hypermethylation in cisplatin treatment response of male germ cell tumors. Mol. Cancer 3:16.

Schmidt, H.H., Dyomin, V., Palanisamy, N., Itoyama, T., Nanjangud, G., Pric-Danoewinata, H., Haas, O.A., Chaganti, R.S.K. Deregulation of the carbohydrate (chondroitin 4) sulfotransferase II (CHSTII) gene in B-cellchronic lymphocytic leukemia with a t(12;14)(q23;q32). Oncogene. 23: 6991-6996, 2004.

Chadalavada, R.S., Houldsworth, J., Olshen, A.B., Bosl, G.J., Studer, L., Chaganti, R.S.K. Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent embryonal carcinoma cells. Funct. Integr. Genomics. 5: 59-69, 2005.

Houldsworth, J., Bosl, G.J., and Chaganti, R.S.K. Genetics and biology of adult male germ cell tumors. In: Urological Cancers: Science and Treatment (Waxman, J., ed) Springer Verlag, London, pp221-229, 2005.

Korkola, J.E., Houldsworth, J., Dobrzynski, D., Olshen, A.B., Reuter, V.E., Bosl, G.J., and Chaganti, R.S. Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene 28: 5101-5107, 2005.

Banerjee, D., Chadalavada, R.S.V., Bourdon, V., Korkola, J.E., Motzer, R.J., and Chaganti, R.S.K. Transcriptional program associated with IFN-á response of renal cell carcinoma. J. Interferon & Cytokine Res. 26: 156-170, 2006.

Chaganti, R.S.K. Testicular cancer. In: Encyclopedia of Life Sciences. John Wily & Sons, Ltd: Chichester, 2006.

Chen, W., Houldsworth, J., Olshen, A.B., Nanjangud, G., Chaganti, S., Venkataraman, E.S., Halaas, J., Teruya-Feldstein, J., Zelenetz, A.D., and Chaganti, R.S.K. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large cell lymphomas. Blood 107:2477-2485, 2006.

Houldsworth, J., Bosl, G.J., and Chaganti, R.S.K. Biology and genetics of adult male germ cell tumors. In: Comprehensive Textbook of Genitourinary Oncology, Third Edition (Vogelzanf, N.J., Scardino, P.T., Shipley, W.U., Debruyne, M.J., Linehan, M., eds), Baltimore, Lippincott Williams & Wilkins, New York, pp563-571, 2005.

Houldsworth J., Korkola, J.E., Bosl, G.J., Chaganti, R.S.K. Biology and genetics of adult male germ cell tumors. J. Clin. Oncol. 24: 5512-5518, 2006.

Korkola, J.E., Houldsworth, J., Chadalavada, R., Olshen A.B., Dobrzynski, D., Reuter, V.E., Bosl, G.J., and Chaganti, R.S.K. Down-regulation of stem cell genes, including those in a 200kb gene cluster at 12p13.31 is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66:820-827, 2006.

Patel, P.H., Chadalavada, S.V., Chaganti, R.S.K., Motzer, R.J. Targeting VHL pathway in renal cell carcinoma. Clin. Cancer Res. 12: 7215-7220, 2006.

Chadalavada, R.S.V., Korkola, J.E., Houldsworth, J., Olshen, A.B., Bosl, G.J., Studer, L., Chaganti, R.S.K. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 embryonal carcinoma cells. Stem Cells 25: 771-8, 2007.

Chaganti, R.S.K. Genetics of cancer. In: Cecil Medicine. 23rd Edition. Saunders, Elsevier, Philadelphia, pp1340-1344, 2007.

Narayan G., Bourdon, V., Chaganti, S., Arias-Pudilo, H., Nandulu, S.V., Rao, P.H., Gissmann, L., Durst, M., Schneider, A., Pothuri, B., Mansukhani, M., Basso, K., Chaganti, R.S.K., Murty, V.V. Gene dosage alterations revealed by cDNA microarrys analysis in cervical cancer: Identification of candidate amplified and overexpressed genes. Genes, Chromosomes & Cancer 46: 373-384, 2007.

Nanjangud, G., Rao, P.H., Teruya-Feldstein, J., Donnelly, G., Qin, J., Mehra, S., Jhanwar, S.C., Zelenetz, A.D., Chaganti, R.S.K. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative sub sets and histologic progression. Cytogenet. Genome Res. 118: 337-344, 2007.

Korkola, J.E., Heck, S., Olshen, A.B., Reuter, V.E., Bosl, G.J., Houldsworth, J., Chaganti, R.S.K. In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes, Chromosomes and Cancer 47: 43-55, 2008.

Bosl, G.J., Bajorin, D.F., Sheinfeld, J., Motzer, R.J., Chaganti, R.S.K. Testis Cancer. In: DeVita, Hellman and Rosenberg’s Cancer: Principles and Practice of Oncology. Eighth Edition (DeVita, V.T., Lawrence, T.S., Rosenberg, S.A., eds). Lippincott Williams & Wilkins, Philadelphia pp 1463-1485.

Houldsworth, J., Petlakh, M., Olshen, A.B., and Chaganti, R.S.K. Pathway activation in large B-Cell non-Hodgkin’s lymphoma cell lines by doxorubicin reveals prognostic markers of In Vivo response. Leukemia & Lymphoma (in press)

Nanjangud, G., Palanisamy, N., and Chaganti, R.S.K. Cytogenetic analysis and related techniques in hematopathology. (Jaffe, E.S., Harris, N.L., Vardiman, J.W., eds), New York (In press).